Discreet monitoring of symptoms in patients with allergic asthma
A wearable device monitors cardiac and blood circulation signals to detect coughing and sneezing events, calculating a respiratory disease exacerbation risk score for early asthma warnings, addressing the inadequacies of current methods in predicting asthma exacerbations.
Patent Information
- Application Number
- JP2022532703
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-01-21
- Filing Date
- 2020-12-22
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2040-12-22
AI Technical Summary
Current methods for predicting asthma exacerbations in patients are inadequate, particularly in daily life settings, as they are burdensome and lack reliability, failing to provide early warnings for allergic reactions and infectious diseases like cold or flu.
A system and method that utilizes a wearable device to measure cardiac and blood circulation signals, detecting coughing and sneezing events to calculate a respiratory disease exacerbation risk score, providing early warnings through a user-friendly interface.
Unobtrusively monitors symptoms to predict asthma exacerbations, allowing timely medication use and effective management, especially for children, by calculating an exacerbation risk score based on detected events and machine learning patterns.
Smart Images

Figure 0007584002000001 
Figure 0007584002000002 
Figure 0007584002000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a system for providing a patient's risk of a respiratory disease exacerbation and a method for providing a patient's risk of a respiratory disease exacerbation. [Background technology]
[0002] The condition of patients with respiratory diseases such as asthma can rapidly deteriorate when they have a cold or flu, as well as when precipitated by an allergic reaction.
[0003] Asthma exacerbations can be fatal, and exacerbations caused by infections are often the most serious. Early detection of symptoms associated with infectious diseases or allergy onset is important to combat them, thereby preventing the deterioration of the patient's respiratory function due to respiratory disease exacerbations caused by the factors mentioned above. Early detection of allergic reactions and cold or flu symptoms alerts the user and allows him to act, in particular to take his regular medication. Most patients do not take their medications 24 / 7, but only when they feel the need. Early warnings can indicate said need before the patient notices asthma symptoms, and can contribute to the patient taking reliever medication with those warnings. For children, this warning to parents helps parents to effectively manage their child's asthma. In general, there is no state-of-the-art method available to reliably predict asthma exacerbations in the patient's daily life. For example, solutions such as monitoring exhalation or peak expiratory flow are not used in practice due to the burden felt by the patient.
[0004] US Patent Publication No. 2019 / 0167176A1 discloses a system for monitoring and treating respiratory distress in a patient, including a signal input, a signal processing unit, and a respiratory distress analysis device. Summary of the Invention [Problem to be solved by the invention]
[0005] For these reasons, it would be advantageous to have a system and method for providing a patient's respiratory disease exacerbation risk score that does not suffer from the drawbacks discussed above. [Means for solving the problem]
[0006] It is an object of the present invention to provide a system and method for providing a patient's risk score for a respiratory disease exacerbation, which unobtrusively monitors symptoms of an allergic reaction or infectious disease, such as the common cold or flu.
[0007] The object of the present invention is solved by the subject matter of the independent claims, further embodiments are incorporated in the dependent claims.
[0008] The described embodiments also relate to systems and methods for providing a score of a patient's risk of exacerbation of a respiratory disease. Although not described in detail herein, synergistic effects may arise from different combinations of these embodiments.
[0009] Furthermore, it should be noted that while all embodiments of the present invention relating to methods may be performed in the order of steps as described, this is not necessarily the only or required order of steps of the method. The methods presented herein can be performed in other orders of steps as disclosed without departing from the respective method embodiments, unless otherwise stated below.
[0010] According to a first aspect of the present invention, there is provided a system for providing a score of a risk of exacerbation of a respiratory disease in a patient. The system comprises a measurement unit configured to measure a cardiac signal and / or a blood circulation signal of the patient and configured to provide corresponding measurement data. The system comprises a detection unit configured to receive the measurement data and to detect a coughing event and / or a sneezing event of the patient in the measurement data. The system comprises a calculation unit configured to calculate a score of a risk of exacerbation of a respiratory disease in the patient based on the detected coughing event and / or the detected sneezing event, and an interface unit configured to provide the exacerbation risk score to a patient and / or a physician.
[0011] The system determines the patient's risk of exacerbation of a respiratory disease, for example by monitoring symptoms such as coughing and sneezing, which may signal the onset of an infection and / or allergy. Symptoms such as coughing and sneezing are derived from measurements of cardiac and / or blood circulation signals. These symptoms may be measured unobtrusively with a measurement unit attached to the patient's body. Coughing and / or sneezing events may be indicative of an upcoming infection or allergy. A detection unit is configured to receive measurement data corresponding to the cardiac and / or blood circulation signals from the measurement unit and to detect coughing and / or sneezing events in the measurement data. A calculation unit calculates an exacerbation risk score indicative of the patient's risk of exacerbation of a respiratory disease based on the detected coughing and / or sneezing events. This exacerbation risk score may be used to update an existing value of the exacerbation risk score obtained in a previous measurement. An interface unit is configured to provide the exacerbation risk score to the patient. Alternatively or additionally, the exacerbation risk score may be provided to the patient's caregiver, which may be a doctor or a parent if the patient is a child.
[0012] In one embodiment of the invention, the blood circulation signal comprises at least one of blood pressure, blood volume and blood flow.
[0013] The blood circulation signal may comprise a blood pressure, a blood volume or a blood flow, also combinations of these are possible.The cardiac signal may correspond to a frequency or an amplitude of a heart beat.
[0014] In one embodiment of the invention, the measuring unit is a wearable unit, for example a bracelet, comprising a first sensor for measuring the heart signal and / or the blood circulation signal.
[0015] The measurement unit can be a wearable device such as a bracelet or wristband with a sensor, which is worn on the patient's wrist or which is attached to another part of the patient's body. A wristband measuring a patient's vital signs is acceptable to the patient and provides an unobtrusive way to measure the patient's heart and blood circulation signals, both during the day and at night.
[0016] In one embodiment of the present invention, the first sensor is a photoplethysmographic sensor.
[0017] The sensor of the measuring unit may be a photoplethysmography sensor. This sensor may comprise a light source for shining light on a part of the patient's body, preferably on the skin, and a photodetector for measuring the light reflected from the skin. This reflected light is influenced by the amount of blood circulating through the skin. Changes in the amount of blood in the skin are caused, for example, by changes in heart rate or blood pressure.
[0018] In one embodiment of the invention, the respiratory disease is asthma or chronic obstructive pulmonary disease.
[0019] The patient's respiratory disease is asthma or chronic obstructive pulmonary disease. In addition, an exacerbation risk score can be provided for any other disease that may worsen when suffering from, for example, an allergic reaction or an infectious disease such as the flu or cold.
[0020] In one embodiment of the invention, the detection unit is configured to detect a cough event by analysing the interbeat interval (IBI) of the cardiac signal.
[0021] The detection unit may rely on changes in the beat interval of the cardiac signal to detect a coughing event, the beat interval being defined as the time elapsed between two subsequent systoles of the cardiac signal, i.e. the time between two heartbeats.
[0022] In one embodiment of the invention, the detection unit is configured to detect a cough event by variation in the length of interbeat intervals over multiple heartbeats.
[0023] The cough detection algorithm of the detection unit may rely on the observation that during a coughing event, the cardiac curve of the cardiac signal measured with the photoplethysmography sensor becomes highly perturbed, and therefore the beat-to-beat intervals vary significantly as well, which can be used to determine a coughing event.
[0024] Furthermore, the cough detection algorithm can ensure that any changes in the cardiac curve detected are due to a cough event and not due to other artifacts, such as relative movement of the light detector or light source of the sensor with respect to the skin. The cough detection algorithm can utilize a patient-specific reference beat interval that is learned by the detection unit when the patient is at rest. This reference beat interval can be learned by the detection unit during initial setup of the system or at run-time by adding an accelerometer to the system to identify the patient's resting state while measuring the reference beat interval. Furthermore, the detection unit can monitor that good contact of the sensor to the skin is ensured. Contact between the skin and the sensor is maintained and a quality check can be performed and tracked by a quality indicator.
[0025] In one embodiment of the invention, the detection unit is configured to detect a sneeze event by analysing the heart rate of a cardiac signal and the blood pressure of a blood circulation signal.
[0026] The detection unit may rely on changes in heart rate in the cardiac signal and changes in blood pressure in the blood circulation signal to detect a sneeze event. Heart rate may be defined as the number of heart beats per unit time. Blood pressure may also be derived from the volume or flow of blood flowing through the patient's skin.
[0027] In one embodiment of the invention, the detection unit is configured to detect a sneeze event by a decreasing heart rate that correlates in time with an increasing blood pressure.
[0028] A sneeze detection algorithm may rely on the patient's body's physiological response that when a patient sneezes, the body's intrathoracic pressure momentarily increases. This can reduce blood flow back to the heart. The heart compensates by momentarily altering and adjusting its rhythmic heartbeat. The detection of a sneeze event is done by correlating the sudden decrease in heart rate with an increase in blood pressure.
[0029] In one embodiment of the invention, the system is configured to store a record of the patient's progression risk score value and provide the record to the patient and / or physician.
[0030] A record of the progression risk score is stored and a trend of the risk score can be provided. Additionally, the system can provide a signal to the patient when the progression risk score is updated, particularly when the progression risk score increases relative to a previous measurement of the progression risk score.
[0031] In one embodiment of the invention, the system comprises a second sensor configured to detect skin contact, temperature and / or acceleration.
[0032] This second sensor can be used to verify the signals detected from the heart and blood circuits being detected. The skin contact sensor can detect whether the first sensor is in good contact with the skin, thereby ensuring that only measurement data is used to detect coughs and sneeze when this first sensor is in good contact with the skin and provides reliable measurement data. The temperature sensor can be used to measure the temperature of the skin, and thus monitor the contact of the first and second sensors with the skin. The acceleration sensor can be used to verify the detected cough and sneeze events, since cough and sneeze events affect body movements. In addition to or instead of the involuntary body movements caused by a cough or sneeze event, the patient can use a hand to cover their mouth, which results in a characteristic acceleration signal of the acceleration sensor, which can be used to verify the occurrence of a cough or sneeze event.
[0033] In one embodiment of the invention, the computation unit comprises an artificial intelligence module configured to be trained with data from a plurality of patients to predict the progression risk score.
[0034] This exacerbation risk score is calculated based on the frequency of detected coughing and sneezing events. The increase or decrease of this score value is based on learning population data. Data on the occurrence of coughing and sneezing events in patients collected as described above can be combined with other data indicative of the likelihood of respiratory disease exacerbation and severity. For example, a patient with an associated reliever inhaler will take one or more puffs of the reliever inhaler in case of an exacerbation, and the number and corresponding frequency of repetitions are indicative of the severity of the exacerbation. Emergency department visits or hospitalizations, and associated physician evaluations, can indicate the severity of this exacerbation. Taking data from a subset of the population with additional data on exacerbations allows the system according to the invention to use machine learning methods to train a model that predicts the risk of exacerbation based on the detected coughing and sneezing events. This machine learning training can ensure that patterns indicative of an upcoming exacerbation are separated from isolated coughs / sneezes. After using machine learning on a subset of the population with additional data on the occurrence of coughing or sneezing events and the corresponding exacerbation risk score, the calculation of the exacerbation risk score can be applied to all patients in the complete population. The exacerbation risk score can also be individualized based on the individual circumstances of the patient. For example, if a person is known to be allergic to certain pollen, the same frequency of coughing / sneezing during the corresponding season will be scored as a higher exacerbation risk score than during other seasons, since the likelihood of exacerbation of respiratory diseases caused by pollen is higher. Another scenario is that on days with poor air quality, i.e. days with poor air quality for a sensitive patient population, the detection of frequent coughing / sneezing events will generate more attention to the risk of exacerbation by scoring higher than days with good air quality.
[0035] According to another aspect of the present invention, there is provided a method for providing a score of a risk of exacerbation of a respiratory disease in a patient, the method comprising the steps of measuring a cardiac signal and / or a blood circulation signal of the patient and providing corresponding measurement data, the method further comprising the steps of detecting a coughing event and / or a sneezing event of the patient based on said measurement data, and calculating a score of a risk of exacerbation of a respiratory disease in the patient based on the detected coughing event and the detected sneezing event, the method further comprising the step of providing said exacerbation risk score to the patient and / or to a physician.
[0036] The method according to the invention provides a score of a risk of exacerbation of a respiratory disease in a patient. In a first step, a cardiac signal and / or a blood circulation signal of the patient are measured and corresponding measurement data are provided. In a second step, based on the measurement data, a coughing event and / or a sneezing event of the patient is detected. In a third step, based on the detected coughing event and / or the detected sneezing event, a score of a risk of exacerbation of a respiratory disease in the patient is calculated. In a fourth step, the exacerbation risk score is provided to the patient and / or to a physician.
[0037] According to another aspect of the invention there is provided a computer program element which, when executed on a processing unit, instructs said processing unit to perform a method according to the above aspect of the invention.
[0038] The computer program element runs on one or more processing units which, when executed, are instructed to perform the method for providing a score of the patient's risk of a respiratory disease exacerbation.
[0039] According to another aspect of the invention there is provided a processing unit arranged to execute a computer program element according to the above aspect of the invention.
[0040] The processing unit is for example a processor of a communication device such as a phone, a smartphone, a tablet, a smartwatch, a bracelet or smart glasses. The processing unit can also be distributed across one or more different devices, such that part of the computer program element runs on the communication device and another part runs, for example, on a server. A bracelet can be communicatively connected to the communication device, and an application installed on this communication device can be configured to perform the steps of the method according to the invention.
[0041] Thus, advantages provided by any of the above aspects apply equally to all other aspects, and vice versa.
[0042] In summary, the present invention relates to a system and method for providing a score of a patient's risk of exacerbation of a respiratory disease. The system measures a patient's cardiac and / or blood circulation signals and detects coughing and sneezing events in the measurement data. Coughing and sneezing events indicate the onset of infectious diseases and / or allergies that may rapidly worsen the patient's respiratory disease. The system is therefore configured to unobtrusively provide a score of the exacerbation risk to the patient and / or physician.
[0043] These aspects and embodiments will be apparent from and will be elucidated with reference to the exemplary embodiments described hereinafter. Exemplary embodiments of the invention are described below with reference to the following drawings, in which: [Brief description of the drawings]
[0044] [Figure 1] FIG. 1 shows a schematic configuration of a system for providing a score of a patient's risk of exacerbation of a respiratory disease according to a first embodiment of the present invention. [Diagram 2] FIG. 2 shows a schematic configuration of a system for providing a score of a patient's respiratory disease exacerbation risk according to a second embodiment of the present invention. [Diagram 3]FIG. 3 shows a schematic configuration of a system for providing a patient's respiratory disease exacerbation risk score according to a third embodiment of the present invention. [Figure 4] FIG. 4 shows the patient's cardiac signal measured by the measurement unit during a coughing event of the patient. [Diagram 5] FIG. 5 shows a block diagram of a method for providing a patient's respiratory disease exacerbation risk score according to one embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0045] 1 shows a schematic configuration of a system 100 for providing a respiratory disease exacerbation risk score 170 of a patient 150 according to a first embodiment of the present invention. A measurement unit 110 measures a cardiac signal and / or a blood circulation signal of the patient 150. Measurement data 160 corresponding to the cardiac signal and / or the blood circulation signal is provided and received by a detection unit 120. The detection unit 120 is configured to detect a coughing event and / or a sneezing event 165 of the patient 150 in the measurement data 160. A calculation unit 130 is configured to calculate a respiratory disease exacerbation risk score 170 of the patient. This exacerbation risk score 170 is provided to the patient 150 and / or a physician by an interface unit 140.
[0046] Fig. 2 shows a schematic configuration of a system 100 for providing a score 170 of a risk of exacerbation of a respiratory disease of a patient 150 according to a second embodiment of the invention. In this embodiment of the invention, the measurement unit 110 is a wearable device 180 comprising a first sensor 181 and a second sensor 182. The first sensor 181 is configured to measure a cardiac signal and / or a blood circulation signal of the patient 150. The second sensor 182 is configured to measure a contact with the skin and thus provides data on the reliability of the data measured by the first sensor 181. The measurement data 160 are transmitted to a communication device 300 such as a smartphone, a tablet, a smart watch, smart glasses, etc. However, the wearable device 180 can for example be a smart watch, i.e. the wearable device 180 can comprise a detection unit 120, a calculation unit 130 and an interface unit 140. The communication device comprises in this embodiment of the invention a detection unit 120 for receiving the measurement data 160 and for detecting a coughing event and / or a sneezing event 165. These are provided to the calculation unit 130, which comprises an artificial intelligence module 190 trained to provide an progression risk score 170. The progression risk score 170 is provided to the patient 150 and / or the physician by the interface unit 140. The processing unit 200 can be communicatively connected to the detection unit 120, the calculation unit 130 and the interface unit 140 and is configured to control the detection unit 120, the calculation unit 130 and the interface unit 140 and to perform the steps of the method according to the invention.
[0047] 3 shows a schematic configuration of a system 100 for providing a respiratory disease exacerbation risk score 170 of a patient 150 according to a third embodiment of the present invention. A wearable device 180 is attached to the wrist of the patient 150. The wearable device 180 can be communicatively connected to a communication device 300, for example by a wireless connection such as WLAN or Bluetooth.
[0048] 4 shows the cardiac signal of the patient 150 measured by the measurement unit 110 during a coughing event 165 of the patient 150. The amplitude A of the signal measured by the measurement unit 110, in the absence of coughing and / or sneezing events, usually shows a regular curve-like waveform measured over time t. In the time interval starting at t1 and ending at t2, a coughing event 165 is detected due to a disruption of said regular waveform with highly fluctuating beat-to-beat intervals.
[0049] Fig. 5 shows a block diagram of a method for providing a respiratory disease exacerbation risk score 170 of a patient 150 according to an embodiment of the present invention. The method comprises a first step 160 of measuring the patient's heart and / or blood circulation signals and providing corresponding measurement data. This step is followed by a second step of detecting coughing and / or sneezing events 165 of the patient 150 based on said measurement data 160. A third step comprises calculating a respiratory disease exacerbation risk score 170 of the patient 150 based on the detected coughing and / or sneezing events 165. In a fourth step, the exacerbation risk score 170 is provided to the patient 150 and / or to a physician.
[0050] While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered exemplary or explanatory and not restrictive. The invention is not limited to the disclosed embodiments. Variations to the disclosed embodiments can be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims.
[0051] In the claims, the word "comprising" does not exclude other elements or steps, nor does it exclude a plurality of them, even if a plurality is not stated. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage. Any reference signs in the claims should not be interpreted as limiting the scope thereof.
Claims
1. 1. A system for providing a respiratory disease exacerbation risk score for a patient, the system comprising: - a measuring unit configured to measure cardiac and / or blood circulation signals of a patient and to provide corresponding measurement data; a detection unit configured to receive the measurement data and to detect coughing and / or sneezing events of the patient in the measurement data, the detection unit comprising: configured to detect the coughing event by analysing the beat intervals of the cardiac signal; and / or configured to detect the sneeze event by analyzing a heart rate of the cardiac signal and a blood pressure of the blood circulation signal. The detection unit, a calculation unit configured to calculate a score of a risk of exacerbation of a respiratory disease of the patient based on the detected coughing event and / or the detected sneezing event; and an interface unit configured to provide said progression risk score to said patient and / or physician; The system has:
2. The system according to claim 1 , wherein the measuring unit is a wearable device in the form of a bracelet having a first sensor for measuring the heart signal and / or the blood circulation signal.
3. The system of claim 2 , wherein the first sensor is a photoplethysmography sensor.
4. The system of claim 1 , wherein the respiratory disease is asthma or chronic obstructive pulmonary disease.
5. The system of claim 1 , wherein the detection unit is configured to detect the cough event by variation in length of the interbeat interval over multiple heartbeats.
6. The system of claim 1 , wherein the detection unit is configured to detect the sneeze event by a decreasing heart rate that correlates in time with an increasing blood pressure.
7. The system of claim 1 , wherein the system is configured to store a record of the patient's progression risk score value and to provide the record to the patient and / or the physician.
8. The system of claim 1 , further comprising a second sensor configured to detect skin contact, temperature and / or acceleration.
9. 9. The system of claim 1, wherein the computation unit comprises an artificial intelligence module configured to be trained with data from a plurality of patients to predict the progression risk score.
10. 1. A computer-implemented method for providing a respiratory disease exacerbation risk score for a patient, the computer-implemented method comprising: - measuring cardiac and / or blood circulation signals of a patient and providing corresponding measurement data; detecting a coughing and / or sneezing event of the patient based on the measurement data, the coughing event being detected by analysing the beat intervals of the cardiac signal and / or the sneezing event being detected by analysing the heart rate of the cardiac signal and the blood pressure of the blood circulation signal; calculating a score of the patient's risk of exacerbation of a respiratory disease based on the detected coughing events and / or the detected sneezing events; and providing said progression risk score to said patient and / or physician; 13. A computer-implemented method comprising:
11. 13. A computer program element which, when executed on a processing unit, directs the processing unit to cause the system of claim 1 to perform a method for providing a score of a patient's risk of exacerbation of a respiratory disease, the method comprising: - measuring cardiac and / or blood circulation signals of a patient and providing corresponding measurement data; detecting a coughing and / or sneezing event of the patient based on the measurement data, the coughing event being detected by analysing the beat intervals of the cardiac signal and / or the sneezing event being detected by analysing the heart rate of the cardiac signal and the blood pressure of the blood circulation signal; calculating a respiratory disease exacerbation risk score for the patient based on the detected coughing events and / or the detected sneezing events; and providing said progression risk score to said patient and / or physician; 13. A computer program element comprising:
12. A processing unit configured to execute a computer program element according to claim 11.
Citation Information
Patent Citations
Method for measuring pulmonary function parameters and detecting respiratory-related sleep events from pulmonary artery pressure signals.
JP2010522621A
A Bayesian Causal Network Model for Health Diagnosis and Treatment Based on Patient Data
JP2017537365A
Systems and methods for monitoring and managing chronic diseases
JP2018531055A
Method and apparatus for monitoring respiratory distress based on autonomic imbalance
US20190167176A1
